Topics
What’s in the Retina Pipeline?
SubLiminal Laser for Center-Involving Diabetic Macular Edema
Sponsored by Quantel Medical
View Insert
Retina Pipeline Poster
Business Matters: Maximizing Patient Flow
Editorially independent content supported with advertising by Bausch + Lomb and Regeneron
View Supplement
Epidemiology of Dry AMD and GA
This activity is supported by an unrestricted educational grant from Apellis Pharmaceuticals.
The ACTS Program: Adding Testing to Your Defense Against COVID-19
Sponsored by Avellino
The Surgical Issue
Providing Inflammatory Control in a Patient With Sympathetic Ophthalmia
Sponsored by Bausch + Lomb
Managing Diabetic Macular Edema: Best Practices in Real-World Situations
This activity is supported by an unrestricted educational grant from Allergan.
The Business of Medical Retina: Overcoming Payor Challenges
This activity is supported by supported by an unrestricted educational grant from Regeneron Pharmaceuticals.
What’s Next For nAMD? A Focus On Therapies In The Pipeline
This activity is supported by an unrestricted educational grant from Genentech, a member of the Roche Group.
Diabetic Eye Disease and COVID-19
Business Matters: Avoiding Burnout
Beyond the Anti-VEGFs: An Update on Current and Future AMD Treatment Strategies
COVID-19: Global Retina Responds
Evolutions and Revolutions in Surgical Technology
Sponsored By Alcon
An Exciting Journey in SubLiminal Laser Treatment Therapy for DME
CryoTreq: A New Option For Retinal Cryotherapy
Sponsored by Beaver-Visitec International
The AMD Treatment Burden: Current Status and Promising Solutions
This activity is supported by a grant from Genentech, a member of the Roche Group.
Surviving COVID-19
Business Matters: Surviving the Storm
Choosing the Right Wavelength: Effectiveness of Yellow
Sponsored by LIGHTMED
Diabetic Eye Disease: Expert Discussions on How and When to Treat
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals.
Current and Future Treatments in Age-Related Macular Degeneration: 2019 Year in Review
Photodynamic Therapy in 2020 and Beyond: Current Concepts for Real-World Use
This activity is supported by a grant from Bausch + Lomb.
COVID-19 In Retina
Refining the Use of OCT in Diagnosing Glaucoma
Sponsored by Topcon Healthcare
View Interactive Supplement
Providing Inflammatory Control in a Patient With Relentless Placoid Chorioretinitis
Improved Technology, Speedier Clinics, and Tailored Treatments
Unrestricted Educational Support Provided by ZEISS
Gene Therapy: An Emerging Frontier in the Treatment of Neovascular Diseases
This activity is supported by an independent medical education grant from Adverum Biotechnologies.
Retina Women
Business Matters: Entrepreneurship in Retina
The Role of the New Generation of Lasers in Retina
Insight into Real-World Treatment of nAMD
Techniques and Technologies
Advances in Vitrectomy Probe Technology: The Benefits of Improved Efficiency
Sponsored by Alcon
SS-OCT: Clinical Applications for Diagnosing and Following Ocular Pathology
Navigating the World of Retina: Updates for the Newer Retina Specialist
Supported by unrestricted educational grants from Allergan, Regeneron Pharmaceuticals, and Carl Zeiss Meditec.
Tailoring Therapy to the Neovascular AMD Patient: Implementing Novel Treatment Strategies to Improve Outcomes
Supported by an educational grant from Genentech.
Free Print Subscription
Email Newsletter
Conference Calendar
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
-1_1607102916.jpg?auto=compress,format&w=75)
_1601413920.png?auto=compress,format&w=75)
